Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20170306032913N5
IRCT20170306032913N5
Recruiting
Phase 2

evaluation the effectiveness of neoadjuvant chemoradiation in patient with borderline and unresectable pancreatic cancer

Iran University of Medical Sciences0 sites18 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPancreatic cancer.Malignant neoplasm of pancreas

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Pancreatic cancer.
Sponsor
Iran University of Medical Sciences
Enrollment
18
Status
Recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients over the age of 18 to 75 years who have not previously received chemotherapy or radiotherapy in the upper abdomen, ,
  • •acceptable liver, kidney, and lung function, and acceptable CBC diff
  • •the functional status of group 0 or one according to the ECOG definition.
  • •Patient with borderline and unresectable nonmetastatic pancreatic cancer

Exclusion Criteria

  • •Serious concomitant systemic disorder
  • •Women with a positive pregnancy test or lactating
  • •Previously radiotherapy of upper abdomen
  • •Have endocrine pancreatic tumors or ampullary cancer
  • •Pathology other than pancreatic adenocarcinoma

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A Study on the efficacy of neoadjuvant chemotherapy with carboplatin, docetaxel and bevacizumab in patients with non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung Cancer
JPRN-UMIN000008817ihon University School of Medicine Itabashi Hospital28
Completed
Phase 3
Investigating the effect of neoadjuvant chemotherapy on locally advanced rectal cancerocally advanced Rectal cancers.
IRCT20210308050628N1Hamedan University of Medical Sciences300
Recruiting
Phase 2
eoadjuvant chemotherapy in NSCLCHealth Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungHealth Condition 2: null- stage 2b and 3 Non Small Cell Lung Cancer
CTRI/2016/05/006916investigator initiated study
Completed
Not Applicable
Effect of neoadjuvant chemotherapy in patients with gastric cancer
IRCT2015020220906N1Vice chancellor for Research and Technology30
Not yet recruiting
Phase 2
RESPONSE OF CANCER DRUGS BEFORE SURGERY IN ESOPHAGEAL CANCER AND ALSO COMPARING TWO DIFFERENT CANCER DRUGS COMBINATIONS CISPLATIN PLUS 5FU AND PACLITAXEL AND CARBOPLATIHealth Condition 1: null- Carcinoma esophagus
CTRI/2017/09/009658ALL INDIA INSTITUTE OF MEDICAL SCIENCES